Cargando…

Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology

Probiotics comprise a large group of microorganisms, which have different properties and thus confer different benefits. The use of probiotics has shown promising results in the management of diarrheal diseases. While the availability of probiotic products has flourished in the marketplace, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yeong‐Yeh, Leow, Alex H‐R, Chai, Pei‐Fan, Raja Ali, Raja Affendi, Lee, Way‐Seah, Goh, Khean‐Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812487/
https://www.ncbi.nlm.nih.gov/pubmed/33490608
http://dx.doi.org/10.1002/jgh3.12469
_version_ 1783637678857650176
author Lee, Yeong‐Yeh
Leow, Alex H‐R
Chai, Pei‐Fan
Raja Ali, Raja Affendi
Lee, Way‐Seah
Goh, Khean‐Lee
author_facet Lee, Yeong‐Yeh
Leow, Alex H‐R
Chai, Pei‐Fan
Raja Ali, Raja Affendi
Lee, Way‐Seah
Goh, Khean‐Lee
author_sort Lee, Yeong‐Yeh
collection PubMed
description Probiotics comprise a large group of microorganisms, which have different properties and thus confer different benefits. The use of probiotics has shown promising results in the management of diarrheal diseases. While the availability of probiotic products has flourished in the marketplace, there is limited guidance on the selection of probiotics for clinical use. This position paper is aimed at informing clinicians about the proper selection criteria of probiotics based on current evidence on strain‐specific efficacy and safety for the management of diarrheal diseases. Members of the working group discussed issues on probiotic use in clinical practice, which were then drafted into statements. Literature to support or refute the statements were gathered through a search of medical literature from 2011 to 2020. Recommendations were formulated based on the drafted statements and evidence gathered, revised as necessary, and finalized upon agreement of all members. Twelve statements and recommendations were developed covering the areas of quality control in the manufacturing of probiotics, criteria for selection of probiotics, and established evidence for use of probiotics in diarrheal diseases in adults and children. Recommendations for the use of specific probiotic strains in clinical practice were categorized as proven and probable efficacy based on strength of evidence. Robust evidence is available to support the use of probiotics for diarrheal diseases in clinical practice. Based on the results obtained, we strongly advocate the careful evaluation of products, including manufacturing practices, strain‐specific evidence, and contraindications for at‐risk populations when choosing probiotics for use in clinical practice.
format Online
Article
Text
id pubmed-7812487
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-78124872021-01-22 Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology Lee, Yeong‐Yeh Leow, Alex H‐R Chai, Pei‐Fan Raja Ali, Raja Affendi Lee, Way‐Seah Goh, Khean‐Lee JGH Open Review Articles Probiotics comprise a large group of microorganisms, which have different properties and thus confer different benefits. The use of probiotics has shown promising results in the management of diarrheal diseases. While the availability of probiotic products has flourished in the marketplace, there is limited guidance on the selection of probiotics for clinical use. This position paper is aimed at informing clinicians about the proper selection criteria of probiotics based on current evidence on strain‐specific efficacy and safety for the management of diarrheal diseases. Members of the working group discussed issues on probiotic use in clinical practice, which were then drafted into statements. Literature to support or refute the statements were gathered through a search of medical literature from 2011 to 2020. Recommendations were formulated based on the drafted statements and evidence gathered, revised as necessary, and finalized upon agreement of all members. Twelve statements and recommendations were developed covering the areas of quality control in the manufacturing of probiotics, criteria for selection of probiotics, and established evidence for use of probiotics in diarrheal diseases in adults and children. Recommendations for the use of specific probiotic strains in clinical practice were categorized as proven and probable efficacy based on strength of evidence. Robust evidence is available to support the use of probiotics for diarrheal diseases in clinical practice. Based on the results obtained, we strongly advocate the careful evaluation of products, including manufacturing practices, strain‐specific evidence, and contraindications for at‐risk populations when choosing probiotics for use in clinical practice. Wiley Publishing Asia Pty Ltd 2020-12-12 /pmc/articles/PMC7812487/ /pubmed/33490608 http://dx.doi.org/10.1002/jgh3.12469 Text en © 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Lee, Yeong‐Yeh
Leow, Alex H‐R
Chai, Pei‐Fan
Raja Ali, Raja Affendi
Lee, Way‐Seah
Goh, Khean‐Lee
Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology
title Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology
title_full Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology
title_fullStr Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology
title_full_unstemmed Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology
title_short Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology
title_sort use of probiotics in clinical practice with special reference to diarrheal diseases: a position statement of the malaysian society of gastroenterology and hepatology
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812487/
https://www.ncbi.nlm.nih.gov/pubmed/33490608
http://dx.doi.org/10.1002/jgh3.12469
work_keys_str_mv AT leeyeongyeh useofprobioticsinclinicalpracticewithspecialreferencetodiarrhealdiseasesapositionstatementofthemalaysiansocietyofgastroenterologyandhepatology
AT leowalexhr useofprobioticsinclinicalpracticewithspecialreferencetodiarrhealdiseasesapositionstatementofthemalaysiansocietyofgastroenterologyandhepatology
AT chaipeifan useofprobioticsinclinicalpracticewithspecialreferencetodiarrhealdiseasesapositionstatementofthemalaysiansocietyofgastroenterologyandhepatology
AT rajaalirajaaffendi useofprobioticsinclinicalpracticewithspecialreferencetodiarrhealdiseasesapositionstatementofthemalaysiansocietyofgastroenterologyandhepatology
AT leewayseah useofprobioticsinclinicalpracticewithspecialreferencetodiarrhealdiseasesapositionstatementofthemalaysiansocietyofgastroenterologyandhepatology
AT gohkheanlee useofprobioticsinclinicalpracticewithspecialreferencetodiarrhealdiseasesapositionstatementofthemalaysiansocietyofgastroenterologyandhepatology